NIA-funded conference findings aim at integrating frailty management into person-centered care

NewsGuard 100/100 Score

Though it is one of the most frequently used health indicators as more and more of us age, frailty -- the medical term for increased vulnerability to declines in health or a loss of independence -- remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society (AGS) and the National Institute on Aging (NIA), with support from the Alliance for Academic Internal Medicine (AAIM) and The John A. Hartford Foundation. Conference findings, published in the Journal of the American Geriatrics Society, are poised to advance not only a consensus definition for frailty but also our understanding of its biology, assessment, and role in improving care across several specialties, from cardiology and geriatrics to behavioral and social sciences.

Convened in 2015 for recipients of the NIA's Grants for Early Medical/Surgical Specialists Transition into Aging Research (GEMSSTAR) program, the NIA "U13" conference brought together more than 75 scholars, researchers, leaders in the fields of aging and frailty, and NIA representatives to present and further stimulate research on frailty, particularly across the array of disciplines involved in the high-quality, person-centered care we all will need as we age.

According to the GEMSSTAR conference proceedings, managing frailty is increasingly important in medical specialties to improve quality of life, guide healthcare decision-making, and prevent deteriorating health or the risk for decline, wherever possible. Yet challenges to integrating frailty management into clinical care include not only uncertainty about what to measure but also when, who, and how to do so -- particularly in the context of care addressing other specific health concerns.

Heart failure remains a considerable challenge for us all as we age, for example -- accounting for 1 million hospitalizations and more than $39 billion in healthcare spending per year -- yet the role that frailty plays for people living with heart failure "has been overlooked as a reason for the high-rate of hospital readmission," conference attendees noted. Similar experiences have been reported for everything from end-stage renal disease to treatment for human immunodeficiency virus (HIV) -- reinforcing the importance of understanding frailty's impact on health more clearly.

"Many conditions associated with frailty increase as we age, but it's also incredibly important to remember that we all age differently," said Arti Hurria, MD, a trained geriatrician and oncologist who serves as Director of Cancer and Aging Research at City of Hope in Duarte, CA. Dr. Hurria is also the Principal Investigator on the U13 conference grant. "Integrating frailty screening into our work as clinicians -- identifying individuals at risk, altering treatment when needed, and developing new preventive strategies -- represents a clear path toward the high-quality, person-centered care we all need as we age. That's what this meeting of our GEMSSTAR colleagues is all about."

The NIA's GEMSSTAR program awards support to early-career physicians trained in medical and surgical sub-specialties for research on the role of geriatrics within their specialties. The AGS serves as a central coordinating body for applicants in particular specialties (anesthesiology, emergency medicine, general surgery, gynecology, orthopaedic surgery, physical medicine and rehabilitation, urology, and vascular surgery) interested in applying for the Dennis W. Jahnigen Career Development Award, which provides funding for a Professional Development Plan (PDP) to complement an "R03" research project (the grant mechanism administered by the National Institutes of Health to support small research projects carried out in a short period of time).​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials